Personal profile
Biography
Dr. Forshaw joined NCA&T in 2022. He received his undergraduate degree from the University of the West of England (UWE), Bristol, UK, in Pharmaceutical Sciences, and his Ph.D. also from UWE in Biochemistry. He then completed his postdoctoral training at Wake Forest Baptist Medical Center. Dr. Forshaw is passionate about opening doors to elevate students and teaching about where biology and chemistry intersect. He teaches Biochemistry I, II, lab, and General Biochemistry for graduates. He has an established research lab investigating molecule medicine and protein biochemistry, and funding from the DOD. His research focuses on redox biochemistry, reactive oxygen species, cell signaling, protein oxidation, and omics technology, particularly in cancer and Alzheimer's Disease.
Education/Academic qualification
Biochemistry, Ph.D., University of the West of England
… → 2017
Pharmaceutical sciences, BS, University of the West of England
… → 2012
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Thomas Forshaw is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A proteomics and redox proteomics approach to understanding ARDS heterogeneity
Forshaw, T. E., Shukla, K., Wu, H., Sergeant, S., Lee, J., Tsang, A. W., Morris, P. E., Gibbs, K. W., Files, D. C. & Furdui, C. M., Dec 1 2026, In: Scientific Reports. 16, 1, 6034.Research output: Contribution to journal › Article › peer-review
Open Access -
[18F]Fluoro-DCP, a first generation PET radiotracer for monitoring protein sulfenylation in vivo
Solingapuram Sai, K. K., Chen, X., Li, Z., Zhu, C., Shukla, K., Forshaw, T. E., Wu, H., Vance, S. A., Pathirannahel, B. L., Madonna, M., Dewhirst, M. W., Tsang, A. W., Poole, L. B., Ramanujam, N., King, S. B. & Furdui, C. M., Feb 1 2022, In: Redox Biology. 49, Issue, 102218.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A thiol chemistry perspective on redox medicine
Forshaw, T. E., Tsang, A. W. & Furdui, C. M., 2022, Unknown book. ElsevierResearch output: Chapter in Book/Report/Conference proceeding › Chapter
-
Homozygous knockout of eEF2K alleviates cognitive deficits in APP/PS1 Alzheimer’s disease model mice independent of brain amyloid β pathology
Kasica, N. P., Zhou, X., Jester, H. M., Holland, C. E., Ryazanov, A. G., Forshaw, T. E., Furdui, C. M. & Ma, T., Sep 9 2022, In: Frontiers in Aging Neuroscience. 14, Issue, 959326.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition
Huynh, M. V., Parsonage, D., Forshaw, T. E., Chirasani, V. R., Hobbs, G. A., Wu, H., Lee, J., Furdui, C. M., Poole, L. B. & Campbell, S. L., Aug 1 2022, In: Journal of Biological Chemistry. 298, 8, 102186.Research output: Contribution to journal › Article › peer-review
Open Access16 Scopus citations